A comparison of growth rates of normal thoroughbred foals and foals diagnosed with cervical vertebral malformation

The objectives of this study were to compare the growth rates of normal thoroughbred foals to previously reported growth rates¹ and to compare growth rates of normal foals with foals diagnosed with cervical vertebral malformation (CVM). Fifty-six foals from two foals crops were used, and eight of these foals were diagnosed with CVM. Growth rate analysis of the CVM foals had to be restricted to the period prior to diagnosis because once these foals were diagnosed, they were treated differently from the normal foals. Body measurements taken at 7 day intervals were body weight, wither height, hip height, and heart girth. For statistical analysis, data were broken down into 30 day intervals. Results showed that the growth rates for normal thoroughbred foals have not changed in the past fifteen years. The CVM foals tended to be heavier and taller during some time intervals than the normal foals, but there were no significant differences between the two groups in any of the skeletal growth measurements. Body weight gain was faster in CVM foals from 31–60 d (p<.01), 121–150 d (p<.01), and 211–240 d (P –.05).     

THE EFFECTS OF INTRA-ARTICULAR ANESTHESIA ON SOFT TISSUE-AND BONE-PHASE SCINTIGRAPHY IN THE HORSE

Soft tissue- and bone-phase scintigrams were acquired from 4 normal horses before and over a 14-day period after metacarpophalangeal, antebrachiocarpal, tarsocrural and tarsometatarsal joint blocks. Images were evaluated subjectively and quantitatively for increased activity in these regions. The antebrachiocarpal block resulted in obvious focal accumulation of activity on soft tissue-phase scintigrams. This increased activity was greatest 2 to 4 days postanesthesia and persisted up to 14 days postanesthesia. On quantitative analysis of soft tissue-phase images, similar trends were noted after the metacarpophalangeal and tarsocrural blocks, but these increases were relatively mild and were not evident on subjective evaluation of the images. Abnormal soft tissue-phase activity was not associated with the tarsometatarsal block. On bone-phase scintigrams, increased activity was not present following any of these joint blocks.     

Analogs of growth hormone-releasing hormone induce release of growth hormone in the bovine

Biological potencies of three 29 amino acid growth hormone-releasing hormone analogs (GHRH[1-29]) were determined in the bovine and compared to synthetic human GHRH (44 amino acids; hGHRH[1-44]NH2) for their ability to increase serum growth hormone (GH) concentrations. Four prepubertal Holstein heifers (179 +/- 10 kg) received hGHRH(1-44)NH2 or analogs (D-Ala2, Nle27, Agm29 GHRH[1-29], [JG-73]; D-N-MeAla2, Nle27, Agm29 GHRH[1-29], [JG-75]; and desamino-Tyr1, D-Ala2, Nle27, Agm29 GHRH[1-29], [JG-77]) at the following doses: 0, 6.25, 25, 100 and 400 micrograms/animal. All treatment-dose combinations were administered to each heifer with at least a 1-d interval between treatments. Sixteen blood samples were collected via jugular cannulas 20 min before and up to 6 h after treatment injection. There was a linear dose-dependent GH release in response to hGHRH(1-44)NH2 and the three analogs. Growth hormone peak amplitudes for the three analogs were similar to those observed after administration of the hGHRH(1-44)NH2 (P greater than .05). However, when total area under the GH response curves for each treatment was averaged over all the doses, JG-73 stimulated greater GH release than hGHRH(1-44)NH2 (P less than .05) Heifers injected with the 400-microgram dose of hGHRH(1-44)NH2 or the three analogs showed a primary release of GH followed by a secondary release 1 h later. At all other doses, only a primary GH release was observed.(ABSTRACT TRUNCATED AT 250 WORDS)     

A luteinizing hormone-releasing hormone-induced serum luteinizing hormone surge is not detectable in the milk of cows

Six lactating Holstein cows were used to determine whether a serum luteinizing hormone (LH) surge induced by luteinizing hormone-releasing hormone (LHRH) could be detected in milk. A double antibody radioimmunoassay was evaluated for measuring LH in whole milk. Cows (d 10 of the estrous cycle) were injected with saline (time zero), followed by LHRH 12 h later. Blood samples were collected hourly for 12 h via jugular cannula following each injection; milk removal was accomplished every 2 h by a portable milking machine. On d 10 of the next estrous cycle, treatment, order was switched, with the same cows receiving LHRH at time zero and saline 12 h later. Approximately 2 h following LHRH treatment, serum LH levels peaked at 29 ng/ml and remained elevated for 5 h. There was no corresponding change in milk LH detected during the 12-h to 24-h period following the induced serum LH surge. Our conclusion is that the measurement of LH in the milk of cows shows little promise for predicting ovulation time in the cow.     

The effect of vitamin a supplementation on seminal characteristics and vitamin a absorption in stallions

Fourteen mature stallions were paired based on age and pretreatment spermatozoal output. One member of each pair was assigned to either 1) control (3 ml corn oil) or 2) treated (132,000 IU retinyl palmitate in 3 ml corn oil) experimental groups. Treatments were added to oat rations every other day. Seminal characteristics (gel free volume, gel volume, total seminal volume, percent progressively motile spermatozoa, number of spermatozoa per ml, percentage morphologically normal spermatozoa and spermatozoal membrane stability) and total scrotal width of each stallion were recorded before (February) and after three months of vitamin A supplementation (June). Plasma vitamin A was measured at 0,6,12,24, and 48 hours following the first and last treatments to document absorption. There were no treatment effects (p>.05) on seminal characteristics or scrotal width. Seasonal increases were recorded in gel-free volume, total seminal volume, percent spermatozoal motility, total spermatozoal output, percentage of morphologically normal spermatozoa, and total scrotal width. Plasma vitamin A was lower during the second collection period (June) than the first (February) in both treatment groups. Peak plasma vitamin A was observed 48 hours following ingestion of the first dose of the vitamin but at 12 hours following the last treatment.     

SEPTIC COXOFEMORAL ARTHRITIS AND OSTEOMYELITIS IN A DOG

An 8-year-old male Labrador retriever presented with a rear limb lameness cased by an osteolytic lesion of the left acetabulum and femoral head and neck. Initial bone biopsy study was nondiagnostic. Histopathologic study and culture of the subsequently excised femoral head and neck revealed a Staphyloccocus intermedial arthritis and osteomyelitis. Neoplash was ruled out on the basis of histopathologic analysis.     

A review of calcium, phosphorus and magnesium metabolism in the horse

Mineral metabolism in the equine is a complex process involving absorption sites and interactions between the minerals themselves and other compounds. Factors such as the digestibility of the minerals and the extent of the interactions all play an important role in the mineral amounts required in the diet.Inadequate levels of minerals in the diet can lead to physiological maladies such as HNS and Ricketts. A knowledge and understanding of mineral metabolism is essential to the success of equine management.